MedWatch

Bank needs to see improved GN Group cash flow in fourth quarter

GN Group must improve its cash flow to raise its valuation, says Danske Bank.

Photo: GN Store Nord / PR

Danish bank Danske Bank says it is necessary for GN Group to improve its cash flow, as this is the key for raising the company’s valuation again. Analysts expect to see a positive inflow of more than DKK 3bn (USD 392.5m) from the Danish hearing aid manufacturer next year.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs